Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
SIRIO enhances strategy for small and medium nutra innovators as Lonza’s Sara Lesina joins as GM in Europe
Wednesday, September 07, 2022SIRIO Pharma SIRIO the global nutraceutical contract development and manufacturing organization CDMO appoints a new GM in Europe to drive forward a strategy of targeting small and medium brands launching novel nutraceutical formulations Sara Lesina...
Hovione expands drug product offering with a new manufacturing line dedicated to Continuous Tableting
Tuesday, September 06, 2022Hovione the leader in spray drying and particle engineering announced today that it has expanded its continuous manufacturing offering and services A new stateoftheart continuous manufacturing facility is now coming online at the Loures site in Portu...
QOL Medical, LLC receives FDA approval of Sucraid® (sacrosidase) Oral Solution single-use containers for patients with Congenital Sucrase-Isomaltase Deficiency (CSID)
Tuesday, September 06, 2022QOL Medical LLC a groundbreaking rare disease pharmaceutical company announced today that the United States US Food Drug Administration FDA approved Sucraid singleuse containers for patients more than lb kg with Congenital SucraseIsomaltase Defici...
Zymeworks Announces Release of ESMO Abstract for Phase 1 Study of Zanidatamab Zovodotin (ZW49) in Solid Cancers
Monday, September 05, 2022Zymeworks Inc a clinicalstage biopharmaceutical company developing multifunctional biotherapeutics today announced the release of an abstract by ESMO with preliminary results from the companys Phase study of zanidatamab zovodotin ZW an investigation...
IMFINZI® (durvalumab) Plus Chemotherapy Approved in the US as the First Immunotherapy Regimen for Patients with Advanced Biliary Tract Cancer
Monday, September 05, 2022AstraZenecas IMFINZI durvalumab has been approved in the US for the treatment of adult patients with locally advanced or metastatic biliary tract cancer BTC in combination with chemotherapy gemcitabine plus cisplatin The approval by the Food and Drug...
MC2 Therapeutics announces breakthrough discovery with the potential to help millions of people suffering from urea associated skin diseases
Thursday, September 01, 2022MC Therapeutics AS a commercial stage pharmaceutical company engaged in research and development of novel treatment paradigms for autoimmune and chronic inflammatory skin conditions announces breakthrough discovery of a novel biological paradigm appl...
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.1-Adapted Bivalent COVID-19 Vaccine Booster in European Union
Thursday, September 01, 2022Pfizer Inc and BioNTech SE announced a g booster dose of their Omicron BA Bivalent COVID Vaccine COMIRNATY OriginalOmicron BA g has been recommended for conditional marketing authorization cMA by the European Medicines Agencys EMA Committee for Med...
Thermo Fisher Scientific Showcases Latest Innovations to Improve Biopharmaceutical and Proteomics Workflows
Monday, August 29, 2022IMSC Thermo Fisher Scientific Inc the world leader in serving science is showcasing a new mass spectrometry instrument and consumables that enable biopharmaceutical and proteomics customers to drive scientific breakthroughs and solve analytical cha...
US FDA Approval of IND for CTLA-4 Antibody YH001 for the Treatment of Front-line Sarcoma Patients in Combination with Envafolimab
Monday, August 29, 2022Biocytogen Pharmaceuticals Co Ltd and TRACON Pharmaceuticals Inc today jointly announced that the US Food and Drug Administration FDA has approved the Investigational New Drug IND application for the initiation of a Phase clinical study of YH in com...
Evotec expands clinical and commercial drug substance manufacturing with acquisition of Central Glass Germany
Thursday, August 25, 2022Evotec SE announced today that the Company expands its clinical and commercial manufacturing platform for small molecule therapeutics by acquiring Central Glass Germany GmbH from the Japanese chemical manufacturing company Central Glass Co Ltd Going...
